COX11
Gene Information
- Official Symbol: COX11
- Official Name: cytochrome c oxidase copper chaperone COX11
- Aliases and Previous Symbols: N/A
- Entrez ID: 1353
- UniProt: Q9Y6N1
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Exerts its effect at some terminal stage of cytochrome c oxidase synthesis, probably by being involved in the insertion of the copper B into subunit I. {ECO:0000250}.
Pfam Domains GO Terms
Pfam Domains
| CtaG Cox11 |
GO Terms
| negative regulation of glucokinase activity |
| negative regulation of hexokinase activity |
| regulation of glucokinase activity |
| regulation of hexokinase activity |
| integral component of mitochondrial inner membrane |
| negative regulation of cellular carbohydrate metabolic process |
| negative regulation of carbohydrate metabolic process |
| copper ion binding |
| electron transfer activity |
| regulation of glucose metabolic process |
| regulation of cellular carbohydrate metabolic process |
| electron transport chain |
| regulation of carbohydrate metabolic process |
| negative regulation of kinase activity |
| negative regulation of transferase activity |
| generation of precursor metabolites and energy |
| regulation of small molecule metabolic process |
| negative regulation of phosphorylation |
| negative regulation of phosphate metabolic process |
| negative regulation of phosphorus metabolic process |
| protein-containing complex |
| metal ion homeostasis |
| cation homeostasis |
| inorganic ion homeostasis |
| ion homeostasis |
| negative regulation of catalytic activity |
| regulation of kinase activity |
| oxidation-reduction process |
| regulation of transferase activity |
| chemical homeostasis |
| negative regulation of molecular function |
| mitochondrion |
| regulation of phosphorylation |
| homeostatic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| HMS-I2 10μM R06 exp288 | -2.49 |
| Calcium Ionophore 0.4μM R07 exp342 | 1.7 |
| Hydroxyurea 100μM R07 exp329 | 1.88 |
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| COA3 | 0.671 |
| SELRC1 | 0.656 |
| SCO2 | 0.655 |
| HSD17B10 | 0.641 |
| NARS2 | 0.633 |
| PET117 | 0.627 |
| AARS2 | 0.611 |
| COA6 | 0.601 |
| EARS2 | 0.595 |
| LARS2 | 0.586 |
| YARS2 | 0.585 |
| TARS2 | 0.583 |
| METTL17 | 0.571 |
| PET112 | 0.569 |
| PARS2 | 0.568 |
| COX16 | 0.567 |
| QRSL1 | 0.563 |
| MRPL21 | 0.562 |
| BCS1L | 0.56 |
| MRPS16 | 0.56 |
| FASTKD5 | 0.552 |
| DAP3 | 0.552 |
| RARS2 | 0.549 |
| POLG2 | 0.544 |
| FTSJ2 | 0.544 |
| MRPL23 | 0.539 |
| VARS2 | 0.538 |
| POLG | 0.533 |
| MALSU1 | 0.525 |
| DARS2 | 0.522 |
| MRPS6 | 0.522 |
| GFM2 | 0.519 |
| RPUSD4 | 0.516 |
| MRPS26 | 0.515 |
| WARS2 | 0.514 |
| MRPS21 | 0.509 |
| MRPS5 | 0.508 |
| GTPBP10 | 0.506 |
| FARS2 | 0.505 |
| GFM1 | 0.498 |
| MRPL45 | 0.494 |
| NDUFB11 | 0.488 |
| MTG1 | 0.488 |
| HARS2 | 0.488 |
| COX15 | 0.487 |
| MRPS12 | 0.486 |
| MRPS2 | 0.486 |
| MRPS25 | 0.486 |
| MRPL53 | 0.485 |
| MTG2 | 0.479 |
| MRPS22 | 0.478 |
| GATC | 0.477 |
| MRPS34 | 0.477 |
| COX20 | 0.476 |
| MRPL47 | 0.474 |
| MRPS24 | 0.474 |
| NDUFB6 | 0.473 |
| CARS2 | 0.472 |
| MRPL43 | 0.472 |
| COQ2 | 0.47 |
| MTRF1L | 0.468 |
| MRPL11 | 0.467 |
| MRPL49 | 0.467 |
| COX7B | 0.466 |
| C10orf2 | 0.466 |
| MTPAP | 0.462 |
| MARS2 | 0.461 |
| NDUFAF7 | 0.46 |
| MRPL20 | 0.46 |
| MRPL3 | 0.458 |
| MRPS14 | 0.457 |
| COX6B1 | 0.456 |
| WBSCR16 | 0.455 |
| RNASEH1 | 0.455 |
| DDX28 | 0.454 |
| MRPS27 | 0.454 |
| UQCC1 | 0.454 |
| TEFM | 0.453 |
| ERAL1 | 0.453 |
| COX17 | 0.452 |
| RBFA | 0.452 |
| MRPL39 | 0.449 |
| TFB1M | 0.446 |
| GTPBP8 | 0.445 |
| MCAT | 0.441 |
| MRPS35 | 0.441 |
| PITRM1 | 0.44 |
| MRPL12 | 0.437 |
| KIAA0391 | 0.437 |
| MRPL44 | 0.434 |
| SSBP1 | 0.434 |
| NDUFAF3 | 0.433 |
| MTO1 | 0.429 |
| COX4I1 | 0.429 |
| RPUSD3 | 0.424 |
| C12orf65 | 0.422 |
| NSUN4 | 0.421 |
| MRPL2 | 0.421 |
| POLRMT | 0.421 |
| NDUFA10 | 0.42 |
| MRPS23 | 0.418 |
| TOMM20 | 0.418 |
| NDUFA3 | 0.417 |
| PET100 | 0.416 |
| MRPS10 | 0.416 |
| COQ4 | 0.415 |
| TUFM | 0.415 |
| MRP63 | 0.415 |
| MRPL42 | 0.412 |
| IBA57 | 0.411 |
| MTERFD1 | 0.41 |
| SCO1 | 0.41 |
| ECSIT | 0.409 |
| MRPL4 | 0.409 |
| NDUFS2 | 0.409 |
| ACAD9 | 0.408 |
| MIPEP | 0.407 |
| MRPL18 | 0.407 |
| COX19 | 0.407 |
| TMEM242 | 0.407 |
| NUBPL | 0.406 |
| SARS2 | 0.404 |
| PGM3 | 0.404 |
| MRPS18A | 0.403 |
| COA5 | 0.403 |
| NDUFA2 | 0.403 |
| MRPL38 | 0.402 |
| COX7C | 0.402 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 13/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 2/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 2/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 1/21 |
| liver | 0/20 |
| lung | 1/75 |
| lymphocyte | 1/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 1/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 2/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 1/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 1451
- Expression level (log2 read counts): 5.9
Expression Distribution
COX11 Expression in NALM6 Cells: 5.9